Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers
- Conditions
- CancerLatin America and the Caribbean Code Against Cancer (LAC Code)
- Registration Number
- NCT06965608
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Brief Summary
Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 1200
- Adults (≥18 years old)
- Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
- Healthcare professionals with at least three months of employment at a participating UBS
- Ability to provide informed consent
- Prior diagnosis of any cancer or currently undergoing cancer treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Feasibility of the WhatsApp-Based Intervention Up to 2 weeks after WhatsApp intervention completion Number of participants who report having read at least one WhatsApp message.
Acceptability of the WhatsApp-Based Intervention Up to 2 weeks after WhatsApp intervention completion Mean acceptability score from participant survey (Likert scale 1-5) evaluating message usefulness and clarity.
Appropriateness of the WhatsApp-Based Intervention Up to 2 weeks after WhatsApp intervention completion Proportion of participants who indicate willingness to receive similar messages in the future (Yes/No).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
HMAP - Hospital Municipal de Aparecida de Goiânia
🇧🇷Aparecida de Goiania, GO, Brazil